Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. aged greater than 20 years who have persistent H. pylori infection after two treatments and are willing to receive third line rescue regimens.~Exclusion Criteria:~1. children and teenagers aged less than 20 years,~2. history of gastrectomy,~3. gastric malignancy, including adenocarcinoma and lymphoma,~4. previous allergic reaction to antibiotics (Amolin, Klaricid, Cravit) and prompt pump inhibitors (esomeprazole),~5. contraindication to treatment drugs,~6. pregnant or lactating women,~7. severe concurrent disease.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- sequential, susceptibility guided (Type: EXPERIMENTAL): single arm

Based on this trial design, predict the completion outcome and termination type (if applicable).